Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocrine causes of nonalcoholic fatty liver disease
Laura Marino, François R. Jornayvaz
World Journal of Gastroenterology (2015) Vol. 21, Iss. 39, pp. 11053-11053
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Ovarian hormones and obesity
Brigitte Leeners, Nori Geary, Philippe N. Tobler, et al.
Human Reproduction Update (2016) Vol. 23, Iss. 3, pp. 300-321
Open Access | Times Cited: 335
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello, Antonino Di Pino, Roberto Scicali, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1948-1948
Open Access | Times Cited: 171
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones
Caroline E. Geisler, Benjamin J. Renquist
Journal of Endocrinology (2017) Vol. 234, Iss. 1, pp. R1-R21
Open Access | Times Cited: 164
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
Ludovico Abenavoli, Nataša Milić, Laura Di Renzo, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 31, pp. 7006-7006
Open Access | Times Cited: 153
Nonalcoholic fatty liver disease as a multi-systemic disease
Hakan Fotbolcu, Elçin Zorlu
World Journal of Gastroenterology (2016) Vol. 22, Iss. 16, pp. 4079-4079
Open Access | Times Cited: 123
Mitochondrial-Derived Peptides Are Down Regulated in Diabetes Subjects
Manjunath Ramanjaneya, Ilham Bettahi, Jayakumar Jerobin, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 82
Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD
Maria Mavromati, François R. Jornayvaz
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12797-12797
Open Access | Times Cited: 75
Pathophysiology of NASH in endocrine diseases
Karim Gariani, François R. Jornayvaz
Endocrine Connections (2021) Vol. 10, Iss. 2, pp. R52-R65
Open Access | Times Cited: 63
Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
Clarissa Berardo, Laura Giuseppina Di Pasqua, Marta Cagna, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9646-9646
Open Access | Times Cited: 60
Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats
Peng Cui, Wei Hu, Tong Ma, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 208, pp. 105829-105829
Open Access | Times Cited: 42
Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
Myeong Jun Song, Jong Young Choi
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 36
Thyroid hormone action and liver disease, a complex interplay
Luigi Marino, Adam Kim, Bin Ni, et al.
Hepatology (2023)
Open Access | Times Cited: 18
Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study
Matina Kouvari, Laura Valenzuela‐Vallejo, Evangelos Axarloglou, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 848-864
Open Access | Times Cited: 7
Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases
Ruben Vazquez-Uribe, Karl Alex Hedin, Tine Rask Licht, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 6
Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
Anna Jeznach–Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka–Senczyna, et al.
Medicina (2019) Vol. 55, Iss. 5, pp. 166-166
Open Access | Times Cited: 48
Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review
Madalena von Hafe, Marta Borges‐Canha, Catarina Vale, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 298-298
Open Access | Times Cited: 25
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
Patrice Marqués, Vera Francisco, Laura Martínez‐Arenas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2313-2313
Open Access | Times Cited: 16
Obesity disrupts the pituitary-hepatic UPR communication leading to NAFLD progression
Qingwen Qian, Mark Junjie Li, Zeyuan Zhang, et al.
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1550-1565.e9
Closed Access | Times Cited: 5
Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease
Kazuki Tahara, Takemi Akahane, Tadashi Namisaki, et al.
JGH Open (2019) Vol. 4, Iss. 3, pp. 400-404
Open Access | Times Cited: 40
Consenso mexicano de la enfermedad por hígado graso no alcohólico
Raúl Bernal-Reyes, Graciela Castro‐Narro, R. Malé-Velázquez, et al.
Revista de Gastroenterología de México (2019) Vol. 84, Iss. 1, pp. 69-99
Open Access | Times Cited: 36
The association of sex steroid hormone concentrations with non‐alcoholic fatty liver disease and liver enzymes in US men
Hong Phan, Aline Richard, Mariana Lazo, et al.
Liver International (2020) Vol. 41, Iss. 2, pp. 300-310
Open Access | Times Cited: 35
The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity
Ying Wang, Shuyi Yang, Suming Zhang, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
The Mexican consensus on nonalcoholic fatty liver disease
Raúl Bernal-Reyes, Graciela Castro‐Narro, R. Malé-Velázquez, et al.
Revista de Gastroenterología de México (English Edition) (2019) Vol. 84, Iss. 1, pp. 69-99
Open Access | Times Cited: 30
Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
Sara Arefhosseini, Mehrangiz Ebrahimi‐Mameghani, Farzad Najafipour, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18
New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
Yadi Wang, Liang-Liang Wu, Xiaoyan Qi, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 799-812
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top